Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy
Liver cirrhosis (LC) is a fibrotic lesion of liver tissue caused by the repeated progression of chronic hepatitis. The traditional Chinese medicine Gexia-Zhuyu formula (GXZY) has a therapeutic effect on LC. However, its pharmacological mechanisms on LC remain elucidated. Here, we used the network ph...
Saved in:
Main Authors: | Xu Cao (Author), Yijun Liang (Author), Ruijia Liu (Author), Xiaobin Zao (Author), Jiaying Zhang (Author), Guang Chen (Author), Ruijie Liu (Author), Hening Chen (Author), Yannan He (Author), Jiaxin Zhang (Author), Yong'an Ye (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis
by: Yuhao Yao, et al.
Published: (2022) -
Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma
by: Xu Cao, et al.
Published: (2022) -
Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and in vivo/vitro experiment verification
by: Xu Cao, et al.
Published: (2023) -
The Chinese herbal KangXianYiAi formula inhibits hepatocellular carcinoma by reducing glutathione and inducing ferroptosis
by: Xiaobin Zao, et al.
Published: (2023) -
Application of network pharmacology in traditional Chinese medicine for the treatment of digestive system diseases
by: Shihao Zheng, et al.
Published: (2024)